Suppr超能文献

不依赖RGD的细胞与纤连蛋白羧基末端肝素结合片段的黏附涉及依赖肝素和不依赖肝素的活性。

RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.

作者信息

McCarthy J B, Skubitz A P, Qi Z, Yi X Y, Mickelson D J, Klein D J, Furcht L T

机构信息

University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis.

出版信息

J Cell Biol. 1990 Mar;110(3):777-87. doi: 10.1083/jcb.110.3.777.

Abstract

Cell adhesion to extracellular matrix components such as fibronectin has a complex basis, involving multiple determinants on the molecule that react with discrete cell surface macromolecules. Our previous results have demonstrated that normal and transformed cells adhere and spread on a 33-kD heparin binding fragment that originates from the carboxy-terminal end of particular isoforms (A-chains) of human fibronectin. This fragment promotes melanoma adhesion and spreading in an arginyl-glycyl-aspartyl-serine (RGDS) independent manner, suggesting that cell adhesion to this region of fibronectin is independent of the typical RGD/integrin-mediated binding. Two synthetic peptides from this region of fibronectin were recently identified that bound [3H]heparin in a solid-phase assay and promoted the adhesion and spreading of melanoma cells (McCarthy, J. B., M. K. Chelberg, D. J. Mickelson, and L. T. Furcht. 1988. Biochemistry. 27:1380-1388). The current studies further define the cell adhesion and heparin binding properties of one of these synthetic peptides. This peptide, termed peptide I, has the sequence YEKPGSP-PREVVPRPRPGV and represents residues 1906-1924 of human plasma fibronectin. In addition to promoting RGD-independent melanoma adhesion and spreading in a concentration-dependent manner, this peptide significantly inhibited cell adhesion to the 33-kD fragment or intact fibronectin. Polyclonal antibodies generated against peptide I also significantly inhibited cell adhesion to the peptide, to the 33-kD fragment, but had minimal effect on melanoma adhesion to fibronectin. Anti-peptide I antibodies also partially inhibited [3H]heparin binding to fibronectin, suggesting that peptide I represents a major heparin binding domain on the intact molecule. The cell adhesion activity of another peptide from the 33-kD fragment, termed CS1 (Humphries, M. J., A. Komoriya, S. K. Akiyama, K. Olden, and K. M. Yamada. 1987. J. Biol. Chem., 262:6886-6892) was contrasted with peptide I. Whereas both peptides promoted RGD-independent cell adhesion, peptide CS1 failed to bind heparin, and exogenous peptide CS1 failed to inhibit peptide I-mediated cell adhesion. The results demonstrate a role for distinct heparin-dependent and -independent cell adhesion determinants on the 33-kD fragment, neither of which are related to the RGD-dependent integrin interaction with fibronectin.

摘要

细胞与细胞外基质成分(如纤连蛋白)的黏附有着复杂的基础,涉及分子上多个与离散细胞表面大分子发生反应的决定因素。我们之前的研究结果表明,正常细胞和转化细胞能在源自人纤连蛋白特定异构体(A链)羧基末端的33-kD肝素结合片段上黏附并铺展。该片段以一种不依赖精氨酰-甘氨酰-天冬氨酰-丝氨酸(RGDS)的方式促进黑色素瘤的黏附与铺展,这表明细胞对纤连蛋白这一区域的黏附独立于典型的RGD/整合素介导的结合。最近从纤连蛋白的这一区域鉴定出两种合成肽,它们在固相分析中能结合[³H]肝素,并促进黑色素瘤细胞的黏附与铺展(麦卡锡,J. B.,M. K. 切尔伯格,D. J. 米克尔森,和L. T. 弗奇特。1988年。《生物化学》。27:1380 - 1388)。当前的研究进一步明确了其中一种合成肽的细胞黏附及肝素结合特性。这种肽被称为肽I,其序列为YEKPGSP - PREVVPRPRPGV,代表了人血浆纤连蛋白的1906 - 1924位残基。除了以浓度依赖的方式促进不依赖RGD的黑色素瘤黏附与铺展外,该肽还显著抑制细胞对33-kD片段或完整纤连蛋白的黏附。针对肽I产生的多克隆抗体也显著抑制细胞对该肽以及对33-kD片段的黏附,但对黑色素瘤细胞与纤连蛋白的黏附影响极小。抗肽I抗体也部分抑制了[³H]肝素与纤连蛋白的结合,这表明肽I代表了完整分子上一个主要的肝素结合结构域。将来自33-kD片段的另一种肽(称为CS1,汉弗莱斯,M. J.,A. 小森,S. K. 秋山,K. 奥尔登,和K., M. 山田。1987年。《生物化学杂志》,262:6886 - 6892)的细胞黏附活性与肽I进行了对比。虽然两种肽都促进不依赖RGD的细胞黏附,但肽CS1不能结合肝素,并且外源性肽CS1也不能抑制肽I介导的细胞黏附。结果表明,在33-kD片段上存在不同的依赖肝素和不依赖肝素的细胞黏附决定因素,它们都与RGD依赖的整合素与纤连蛋白的相互作用无关。

相似文献

引用本文的文献

本文引用的文献

10
Molecular biology of fibronectin.纤连蛋白的分子生物学
Annu Rev Cell Biol. 1985;1:67-90. doi: 10.1146/annurev.cb.01.110185.000435.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验